Study: Vaping Helped in Resolving a Chronic Nasal Infection

Published by Paul Larter on 2nd May 2019

Recent studies have proved, from several documented cases that vaping helped resolved chronic respiratory bacterial infections

In 2017, Peter Hajek and Joanna Miler published a paper, “chronic tonsillitis resolution in an individual with no smoking history who became a vaper. A case study and new hypothesis” where an individual without any history of smoking who suffered chronic tonsillitis experienced significant improvements after some periods of vaping.

According to the researchers; “we have recently reported and documented a correlation between chronic throat infection resolution and vaping in an individual with no smoking history. There are two humectants utilized by E-cigarette liquids; vegetable glycerol and propylene glycol (PG). The observed vaping effect could be as a result of virucidal and bactericidal properties exerted by the PG.

Vaping resolved two different chronic infections types

A doctor with similar results has been in contact with the researchers following this publication. They have this to say; “Consequent to this report, a medical doctor with no history of smoking has reported cases of chronic nasal infection resolution due to the use of e-liquid with vegetable glycol as the only content.”

Another paper with title: “Chronic nasal Staphylococcus aureus infection resolution in a non-smoker who adopted the use of glycerine-based e-cigarettes: Could this be Vaping Antibacterial effects?” also reported a case of complete nasal Staphylococcus aureus infection resolution in an individual with no smoking history after some weeks of using his wife’s e-cigarette which contained vegetable glycerine with low nicotine levels (3 mg/ml).

Some compounds in e-liquids may have antimicrobial properties

According to the duo, Hajek, and Miler, this infection resolution could be as a result of the properties of the compounds found in the vaping product, though there are still possibilities of mere coincidence.

In a statement; “there is no way that such improvements would be attributed to bacterial effect of PG or smoking cessation. There could be a trace to the antimicrobial effects of nicotine and/or nicotine complex or the bacteriostatic effects of glycerol”

The researchers concluded by saying that “using nicotine levels and humectants to assess the effects of e-cigarettes in patients with chronic respiratory infections could provide more clarity to this problem and provide a clue to treatment options”.